10.57
0.00
(0.00%)
As of January 2 at 3:29:01 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 7 | 7 |
| Avg. Estimate | 163.07M | 162.19M | 599.48M | 655.4M |
| Low Estimate | 160.7M | 159.01M | 597.2M | 633.49M |
| High Estimate | 165M | 166.52M | 601.5M | 669.8M |
| Year Ago Sales | 143.37M | 143.8M | 549.3M | 599.48M |
| Sales Growth (year/est) | 13.74% | 12.79% | 9.14% | 9.33% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6RR.F | -- | -- | -- | -- |
| S&P 500 | 8.39% | 11.26% | 13.82% | 13.53% |
Upgrades & Downgrades
| Maintains | Northland Capital Markets: Outperform to Outperform | 12/17/2024 |
| Upgrade | Wells Fargo: Equal-Weight to Overweight | 12/9/2024 |
| Maintains | UBS: Neutral to Neutral | 11/5/2024 |
| Initiated | Northland Capital Markets: Outperform | 9/16/2024 |
| Maintains | Baird: Neutral to Neutral | 8/7/2024 |
| Maintains | Wedbush: Outperform to Outperform | 8/7/2024 |